Hang Seng Index Rebounds 393 Points as Biotech, Chip Stocks Rally
SingTao · 4 SOURCESabout 3 hours ago7 MIN
Summary
Hong Kong's Hang Seng Index staged a strong comeback on Wednesday (November 4), reversing an early 140-point decline to close 393 points higher at 23,919 — its fourth consecutive session of gains. The rally was broad-based, with biotech and semiconductor stocks leading the advance, while technology majors showed mixed results. Trading volume reached HK$236.8 billion, reflecting renewed investor interest in Hong Kong equities amid a backdrop of geopolitical uncertainty and shifting sector dynamics.
Key Points
- The Hang Seng Index opened down 74 points at 23,451 before plummeting to an intraday low of 23,385, but recovered sharply to close at 23,919, a gain of 393 points or 1.67% . The State-owned Enterprise Index rose 114 points to 8,057, while the Tech Index climbed 68 points to 3,936 .
- Biotech stocks dominated the leaderboard, with WuXi AppTec surging 12.3%, WuXi Biologics jumping 12.2%, and BeiGene rising 10% — making them the three best-performing blue chips . These gains came despite broader weakness in the technology sector.
- Semiconductor stocks also posted exceptional gains, with China Semiconductor Manufacturing International Corp (SMIC) climbing 8.9% and Hua Hong Grace Semiconductor manufacturing Co. Ltd. surging 15.7%, the top-performing blue chip . In contrast, electric vehicle manufacturers and AI model companies including XPeng, NIO, Li Auto, MiniMax, and Zhipu fell more than 3% .
- Large technology stocks were mixed: Tencent Holdings gained 1.1% to close at HK$395.4, Alibaba Group rose 1% to HK$97.6, Meituan added 1.1% to HK$74.2, while Xiaomi Group edged up 0.5% and JD.com slipped 0.7% . The half-day session saw heavier losses, with Alibaba down 1.96% and JD.com down 1.77% .
- Southbound trading from mainland investors (北水) recorded net buying of HK$23.42 billion on Tuesday, with the Tracker Fund of Hong Kong (盈富基金) attracting HK$16.507 billion, and Southbound-traded Southern Hang Seng Tech ETF receiving HK$4.315 billion .
Why It Matters
The sharp sector rotation toward biotech and chip stocks reflects growing investor concern about cash flow sustainability in the semiconductor industry amid elevated capital expenditure . This shift, catalyzed by the People's Bank of China's new swap facility program designed to enhance market liquidity, signals a reallocation of capital toward high-dividend and financial stocks . For Hong Kong investors, the divergent performance between traditional tech heavyweights and emerging sectors like biotech suggests that stock-specific analysis may prove more rewarding than broad market exposure in the near term.
The sharp sector rotation toward biotech and chip stocks reflects growing investor concern about cash flow sustainability in the semiconductor industry amid elevated capital expenditure . This shift, catalyzed by the People's Bank of China's new swap facility program designed to enhance market liquidity, signals a reallocation of capital toward high-dividend and financial stocks . For Hong Kong investors, the divergent performance between traditional tech heavyweights and emerging sectors like biotech suggests that stock-specific analysis may prove more rewarding than broad market exposure in the near term.